Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2018-10-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The incidence of brain tumors in people with epilepsy is approximately 4%. Among patients with brain tumor (s), the frequency of epilepsy is 30% or more depending on type of tumeur. 30-50% of brain tumors are revealed by an epileptic seizure and 10 to 30% of patients with brain tumor (s) will develop seizures during their evolution.
The main objective is to evaluate the frequency of epileptic seizures according to the type of brain tumor.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epilepsy-Associated Stigma
NCT01374204
Epidemiology of Suspected Epileptic Seizures
NCT04147663
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
NCT05126914
Tumor Related Epilepsy
NCT02639325
Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children
NCT02821260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient hospitalized or seen in consultation in the Department of Neurology within the Hospital Group Paris Saint-Joseph
* Diagnosis of primary or secondary brain tumor, radiologically and / or histologically
* Epilepsy revealing or occurring in a patient developing a brain tumor
* Francophone patient
Exclusion Criteria
* Epilepsy occurring within 2 weeks postoperatively
* Anteriority of taking antiepileptic treatment
* Patient under tutorship or curatorship
* Patient deprived of liberty
* Patient with comprehension disorders making it impossible to understand the protocol
* Patient or relative opposing the use of his data
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Hôpital Saint-Joseph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roubeau Vincent, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Hôpital Saint-Joseph
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Epilepsy-related brain tumors
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.